Assess Parkinson symptoms in Italian
- Trial ID
- NCT07316751
- Official Title
- Italian Translation and Validation of the GIDS-PD Scale for Parkinson's Disease
- Goal
- Assess Parkinson symptoms in Italian
- Status
- RECRUITING
- Sponsor
- Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
- Study Type
- OBSERVATIONAL
- Enrollment
- 190 participants
- Conditions
- PARKINSON DISEASE (Disorder), Parkinson Disease
Plain-Language Summary
The goal is to produce and validate an Italian version of the GIDS-PD scale so clinicians and researchers have a reliable tool to measure Parkinson's symptom severity and how those symptoms affect daily life in Italian-speaking patients. The team will translate the questionnaire and then test it in about 190 people, checking that the questions are clear, consistent, and accurately reflect patients' symptoms and function; no drug or device is given because it is an observational validation. Adults 18 and older with Parkinson's diagnosed by the MDS criteria who understand Italian and can give consent are eligible, while people in the terminal phase, with significant cognitive impairment, or with non-PD parkinsonism are excluded.
Locations
- Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
- Ospedale Universitario Luigi Sacco, Milano, Italia, Milan, Italy
- Unità Parkinson e Disturbi del Movimento, Dipartimento di Neuroscienze(DNS), Università di Padova, Padova, Italia, Padova, Italy
- Centro per le Malattie Neurodegenerative e l'Invecchiamento Cerebrale, Università degli Studi di Bari "Aldo Moro" presso la Pia Fondazione "Card. G. Panico", Tricase, Italia, Tricase, Italy
- Unità di Neurologia, Divisione Malattia di Parkinson e Disturbi del Movimento, Dipartimento di Neuroscienze, Biomedicina e Scienze del Movimento, Università di Verona, Italia, Verona, Italy
Frequently Asked Questions
- What is this trial testing?
- This trial is studying an experimental treatment. The goal is to produce and validate an Italian version of the GIDS-PD scale so clinicians and researchers have a reliable tool to measure Parkinson's symptom severity and how those symptoms affect daily life in Italian-speaking patients. The team will translate the questionnaire and then test it in about 190 people, checking that the questions are clear, consistent, and accurately reflect patients' symptoms and function; no drug or device is given because it is an observational validation. Adults 18 and older with Parkinson's diagnosed by the MDS criteria who understand Italian and can give consent are eligible, while people in the terminal phase, with significant cognitive impairment, or with non-PD parkinsonism are excluded.
- Who can participate?
- Participants must be at least 18 Years.
- Where is this trial located?
- This trial is recruiting at 5 locations.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 3 years and 1 month.